CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE OMISSIONS HAVE BEEN INDICATED BY “[***].”Exclusive License Agreement • November 8th, 2019 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations
This Agreement is dated September 19, 2019 (the “Effective Date”), and is between THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, a New York corporation (“Columbia”), and TONIX PHARMACEUTICALS, INC., a Delaware corporation (“Company” or “Tonix”). Columbia and Company agree as follows:
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 8th, 2019 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (“Agreement”), dated August 19, 2019 (the “Effective Date”), is entered into by and among TRImaran Pharma, Inc., a Delaware corporation (“Seller”), Tonix Pharmaceuticals, Inc., a Delaware corporation (“Buyer”) and, solely for the purposes of Section 3.1(b), Section 6.1, Section 6.2 and Exhibit F, each of the Seller Shareholders (as defined below).
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE OMISSIONS HAVE BEEN INDICATED BY “[***].” FIRST AMENDED AND RESTATED...Exclusive License Agreement • November 8th, 2019 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations • Michigan
This First Amended and Restated Exclusive License Agreement (“Agreement”) is entered into on August 19, 2019 (the “Execution Date”) and becomes effective as of the Effective Date (as defined below), by and between Wayne State University, a non-profit Michigan educational institution (“WSU” or “Licensor”) and Tonix Pharmaceuticals, Inc. a Delaware corporation duly organized under law and having a usual place of business at 509 Madison Avenue, New York, New York 10022 (“Tonix” or “Licensee”).
